CAR T Cell Immunotherapy for Pancreatic Cancer
University of Pennsylvania
University of Pennsylvania
M.D. Anderson Cancer Center
Massachusetts General Hospital
Actym Therapeutics, Inc.
Amgen
Ikena Oncology
Day One Biopharmaceuticals, Inc.
Biogen
ImmunoGenesis
Fred Hutchinson Cancer Center
Mirati Therapeutics Inc.
Dana-Farber Cancer Institute
BioNTech SE
Merck Sharp & Dohme LLC
The Netherlands Cancer Institute
AbbVie
Mirati Therapeutics Inc.
ABM Therapeutics Corporation
Shanghai PerHum Therapeutics Co., Ltd.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Nerviano Medical Sciences
Washington University School of Medicine
Pfizer
ADC Therapeutics S.A.
Ikena Oncology
OHSU Knight Cancer Institute
Indiana University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Washington University School of Medicine
Fate Therapeutics
4D pharma plc
BioNTech SE
Sorrento Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
MacroGenics
BioNTech SE
AbGenomics B.V Taiwan Branch
Washington University School of Medicine
University Medical Centre Ljubljana
Novartis
Lumos Pharma
Fox Chase Cancer Center
Weill Medical College of Cornell University
Tocagen Inc.
University of Pennsylvania
Celgene
The Cooper Health System
Fox Chase Cancer Center
University of Texas Southwestern Medical Center
Baylor Research Institute